10-Q: Diversified Healthcare Trust Q1 2026 Results Show Net Loss

Sentiment:

Quarterly Report


Diversified Healthcare Trust reported a net loss of $43.3 million for the first quarter of 2026, with revenues declining compared to the prior year.

Worse than expectedThe company reported a net loss of $43.3 million, a significant increase from the $9.0 million net loss in the prior year's quarter.Total revenues decreased by 5.3% to $366.5 million compared to $386.9 million in Q1 2025.The Medical Office and Life Science Portfolio segment experienced a 6.7% decrease in NOI to $25.1 million.Acquisition and other transaction-related costs increased significantly to $3.7 million from $24 thousand.General and administrative expenses rose by 56.0% to $14.0 million, largely due to incentive management fees.

Summary

  • Diversified Healthcare Trust (DHC) reported a net loss of $43.3 million for the first quarter ended March 31, 2026, compared to a net loss of $9.0 million for the same period in 2025.
  • Total revenues for the quarter were $366.5 million, a decrease from $386.9 million in the first quarter of 2025.
  • The company's SHOP (Senior Living) segment saw an increase in Net Operating Income (NOI) of 18.5% to $43.6 million, driven by higher occupancy and rates.
  • However, the Medical Office and Life Science Portfolio segment experienced a 6.7% decrease in NOI to $25.1 million.
  • Total assets were $4.27 billion as of March 31, 2026, down from $4.36 billion at the end of 2025.
  • Total liabilities decreased to $2.65 billion from $2.70 billion.
  • Shareholders' equity stood at $1.62 billion, down from $1.67 billion.
  • The company acquired two land parcels in Lexington, Kentucky in April 2026 for $14.5 million.
  • DHC sold 13 properties for $23 million during the first quarter of 2026.
  • Moody's upgraded DHC's issuer credit rating from Caa1 to B3 and updated the outlook to positive.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative filing due to the increased net loss and declining revenues, despite some positive operational trends in the SHOP segment and a credit rating upgrade.

Positives

  • The SHOP segment demonstrated strong performance with an 18.5% increase in Net Operating Income (NOI) to $43.6 million, driven by improved occupancy and average monthly rates.
  • The company's Medical Office and Life Science Portfolio segment saw a 3.7% increase in NOI on a comparable properties basis.
  • Moody's Investors Service upgraded DHC's issuer credit rating from Caa1 to B3, and its senior secured notes rating from B3 to B2, with a positive outlook, indicating improved creditworthiness.
  • The company had $150 million available for borrowings under its revolving credit facility as of March 31, 2026.
  • The company believes its current sources of cash will be sufficient to meet operating and capital expenses, debt obligations, and distributions for at least the next 12 months and beyond.

Negatives

  • The company reported a net loss of $43.3 million for the quarter, a significant increase from the $9.0 million net loss in the prior year's quarter.
  • Total revenues decreased by 5.3% to $366.5 million compared to $386.9 million in Q1 2025.
  • The Medical Office and Life Science Portfolio segment experienced a 6.7% decrease in NOI to $25.1 million.
  • Acquisition and other transaction-related costs increased significantly to $3.7 million from $24 thousand.
  • General and administrative expenses rose by 56.0% to $14.0 million, largely due to incentive management fees.
  • The company incurred a $38.5 million impairment of assets in the prior year's quarter, which, while not present in the current quarter, contributed to the prior year's results.
  • The company sold 13 properties for $23 million, contributing to a loss on sale of real estate of $1.2 million in the current quarter, compared to a gain of $110.1 million in the prior year.

Risks

  • Uncertainties surrounding interest rates, wage and commodity price inflation, supply chain disruptions, volatility in public debt and equity markets, geopolitical instability, pandemics, economic downturns, and labor market conditions could adversely affect the company, its managers, operators, and tenants.
  • The financial strength of managers, operators, and tenants is a risk factor, as their inability to pay amounts owed could impact DHC.
  • The company faces risks related to the continuing impact of changing market practices, such as the delayed recovery of the senior housing industry and reduced demand for leased space.
  • Costs associated with development, redevelopment, and repositioning activities may be delayed or exceed expectations due to inflation, cost overruns, supply chain challenges, labor shortages, and construction delays.
  • The company is exposed to risks related to government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements.
  • Potential conflicts of interest with related parties, including managing trustees and RMR, are identified as a risk.
  • The company must comply with complex rules to maintain its REIT qualification, and failure to do so could have significant tax implications.

Future Outlook

The company expects favorable supply and demand dynamics in the senior living industry to enable managers to continue to grow occupancy and drive positive performance. While certain costs (labor, insurance, food) have increased, these increases are expected to moderate, allowing for revenue growth exceeding cost increases and improving returns. The company is analyzing non-performing communities for potential disposition or transition to different operators to optimize performance. Redevelopment projects may be deferred to preserve liquidity due to labor availability constraints and inflation.

Management Comments

  • We are encouraged by positive trends, including increases in rates, margins and occupancy in our SHOP segment. Additionally, we expect that favorable supply and demand dynamics in the senior living industry will enable our managers to continue to grow occupancy and drive positive performance.
  • While certain costs, primarily labor, insurance and food costs, have increased, we expect these cost increases to moderate, which will provide our managers the opportunity to increase revenue in excess of increases in costs, resulting in improving returns to us.
  • In an effort to optimize performance, our asset management team reviews the results of each of our senior living communities and our operators, taking into account various factors such as performance metric benchmarks, location and other relevant data points. This comprehensive review process ensures that our decisions are data-driven and strategically aligned with our overall objectives.
  • As a result of these reviews, our strategy to drive positive performance includes analyzing non-performing communities for potential disposition or transition to different operators.

Industry Context

StockSavvy.ai notes that Diversified Healthcare Trust's Q1 2026 results reflect ongoing trends in the healthcare real estate sector, particularly the senior living (SHOP) segment's recovery and the continued pressure on medical office and life science properties. The company's focus on optimizing performance through asset reviews and potential dispositions aligns with industry strategies to navigate market fluctuations and cost pressures.

Comparison to Industry Standards

  • The SHOP segment's occupancy rate of 81.7% for all properties is slightly above the 80.2% reported for the same period in 2025, indicating a positive trend in a sector that has faced challenges.
  • The average monthly rate for the SHOP segment increased to $5,613 from $5,413, suggesting a recovery in pricing power.
  • The Medical Office and Life Science Portfolio segment's occupancy rate of 91.8% for all properties is a significant improvement from 80.6% in Q1 2025, indicating a rebound in demand for these specialized spaces.
  • The company's NOI growth of 4.7% for the total portfolio is a moderate but positive indicator in the current economic climate, with the SHOP segment being the primary driver of this growth.
  • The increase in General and Administrative expenses due to incentive management fees is a common practice among REITs to align management compensation with performance, though the magnitude of the increase here is notable.

Legal Proceedings

  • The company is involved in claims, lawsuits, and regulatory and other governmental audits, investigations, and proceedings arising in the ordinary course of business. Management does not believe any currently pending litigation or proceedings will have a material adverse effect on its financial condition, results of operations, or cash flows.

Related Party Transactions

  • The company has ongoing transactions with RMR, RMR Inc., AlerisLife, and affiliated entities. Adam D. Portnoy, Chair of the Board, is a controlling shareholder and officer of RMR Inc. and an officer of RMR. Other officers of DHC are also officers and employees of RMR Inc. and RMR.
  • DHC leases office space to RMR, recognizing rental income from these leases.
  • AlerisLife, in which DHC holds a 34% stake, paid dividends to its stockholders, including $27.2 million to DHC in January 2026 as part of AlerisLife's business wind-down.

Stakeholder Impact

  • Shareholders: The increased net loss and reduced equity may be concerning. However, the company continues to pay a quarterly distribution of $0.01 per share.
  • Creditors: The credit rating upgrade by Moody's is positive for debt holders, indicating reduced credit risk.
  • Employees: The filing does not directly address employee impact, but increased costs related to labor are noted.
  • Tenants/Residents: The company's ability to manage costs and maintain occupancy and rates will impact the services and rental costs for residents and tenants.

Next Steps

  • Continue to analyze non-performing communities for potential disposition or transition to different operators.
  • Assess opportunities to redevelop other properties in the SHOP and Medical Office and Life Science Portfolio segments.
  • Monitor the impact of economic and market conditions on all aspects of the business.
  • Fund estimated unspent leasing related obligations at medical office and life science properties using operating cash flows and cash on hand.

Key Dates

DateDescription
March 31, 2025End of comparative period for Condensed Consolidated Statements of Comprehensive Income (Loss) and Cash Flows.
December 31, 2025End of comparative period for Condensed Consolidated Balance Sheets.
January 9, 2026AlerisLife paid an aggregate cash dividend of $80,000 to its stockholders, with DHC's pro rata share being $27,200.
March 31, 2026End of period for Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Comprehensive Income (Loss) and Cash Flows.
April 9, 2026Declaration of quarterly distribution to common shareholders.
April 21, 2026Record date for quarterly distribution.
April 2026Acquisition of two land parcels in Lexington, Kentucky.
May 4, 2026Date of certifications for the Form 10-Q.
May 14, 2026Expected payment date for the declared quarterly distribution.

Recommendation

hold

While the credit rating upgrade and positive trends in the SHOP segment are encouraging, the increased net loss, declining revenues, and significant rise in G&A expenses due to incentive fees present considerable headwinds. The company's outlook is mixed, warranting a cautious 'hold' position until a clearer path to sustained profitability emerges and the impact of economic uncertainties is better understood.

Keywords

Diversified Healthcare Trust, DHC, 10-Q, Quarterly Report, Healthcare Real Estate, Senior Living, Medical Office, Life Science, REIT, Net Loss, Revenues, NOI, Capital Expenditures, Debt

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.